<root>
	<PMID Version="1">24362794</PMID>
	<Summary>
		1: Bi J, Bai Z, Ma X, Song J, Guo Y, Zhao J, Yi X, Han S, Zhang Z. Txr1: animportant factor in oxaliplatin resistance in gastric cancer. Med Oncol. 2014Feb;31(2):807. doi: 10.1007/s12032-013-0807-1. Epub 2013 Dec 21. PubMed PMID:24362794.
	</Summary>
	<MeshHeadingList>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D000230">Adenocarcinoma</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
			<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000556">secondary</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D000970">Antineoplastic Agents</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D051778">Basic Helix-Loop-Helix Leucine Zipper Transcription Factors</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D015153">Blotting, Western</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D002453">Cell Cycle</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D049109">Cell Proliferation</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="Y" UI="D019008">Drug Resistance, Neoplasm</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D007124">Immunoenzyme Techniques</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D051034">Inhibitor of Apoptosis Proteins</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D008207">Lymphatic Metastasis</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D009367">Neoplasm Staging</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D009944">Organoplatinum Compounds</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D012333">RNA, Messenger</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D034741">RNA, Small Interfering</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D060888">Real-Time Polymerase Chain Reaction</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D012097">Repressor Proteins</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000037">antagonists &amp;amp; inhibitors</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
			<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D020133">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D013274">Stomach Neoplasms</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
			<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D015996">Survival Rate</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D014407">Tumor Cells, Cultured</DescriptorName>
	    </MeshHeading>
	</MeshHeadingList>
</root>
